The distribution network of a (bio) pharma company depends obviously on the one hand on where life sciences products for the APAC market are manufactured and on the other hand the nature of the product which might require for example temperature controlled handling. Market requirements and propositions of competitors also influence the design of a company supply chain as well as the location of strategic inventory and the chosen route to market. Last but not least, life sciences supply chains are also heavily influenced by regulations and legislation. Especially in a growth market like APAC it is challenging to find the right solution in determining the appropriate cost/service balance to serve specific channel and market combinations. Martin Gouda and Sui Leng Khoo of BCI Global explain which pitfalls to avoid and how.